Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau-based therapies in neurodegeneration: opportunities and challenges
Chuanzhou Li, Jürgen Götz
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 863-883
Closed Access | Times Cited: 225

Showing 26-50 of 225 citing articles:

Alzheimer’s Disease: The Past, Present, and Future of a Globally Progressive Disease
Bhuvanasai Vejandla, Sarah Savani, Rohith Appalaneni, et al.
Cureus (2024)
Open Access | Times Cited: 20
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2
An Overview on the Clinical Development of Tau-Based Therapeutics
Miguel Medina
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1160-1160
Open Access | Times Cited: 150
Clinical Research on Alzheimer’s Disease: Progress and Perspectives
Bin‐Lu Sun, Weiwei Li, Chi Zhu, et al.
Neuroscience Bulletin (2018) Vol. 34, Iss. 6, pp. 1111-1118
Open Access | Times Cited: 139
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders
Vivian Hook, Michael C. Yoon, Charles Mosier, et al.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020) Vol. 1868, Iss. 8, pp. 140428-140428
Open Access | Times Cited: 133
Overview of Transgenic Mouse Models for Alzheimer's Disease
Ariana Myers, Paul McGonigle
Current Protocols in Neuroscience (2019) Vol. 89, Iss. 1
Closed Access | Times Cited: 127
The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
Olga N. Kokiko‐Cochran, Jonathan P. Godbout
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 116
Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
Jean‐Philippe Courade, Rachel Angers, Georges Mairet‐Coello, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 5, pp. 729-745
Open Access | Times Cited: 109
Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease
Sha Ke, Zhaohui Yang, Fei Yang, et al.
Yonsei Medical Journal (2019) Vol. 60, Iss. 7, pp. 640-640
Open Access | Times Cited: 108
Roles of mTOR Signaling in Tissue Regeneration
Xiangyong Wei, Lingfei Luo, Jinzi Chen
Cells (2019) Vol. 8, Iss. 9, pp. 1075-1075
Open Access | Times Cited: 105
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
Stuart P. McCluskey, Christophe Plisson, Eugenii A. Rabiner, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 47, Iss. 2, pp. 451-489
Open Access | Times Cited: 105
Endo/Lysosome‐Escapable Delivery Depot for Improving BBB Transcytosis and Neuron Targeted Therapy of Alzheimer's Disease
Lulu Cai, Chuanyao Yang, Wenfeng Jia, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 27
Closed Access | Times Cited: 103
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Navid Rabiee, Sepideh Ahmadi, Ronak Afshari, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 3
Closed Access | Times Cited: 103
Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers
Yi-Wei Lee, David C. Luther, Jessica A. Kretzmann, et al.
Theranostics (2019) Vol. 9, Iss. 11, pp. 3280-3292
Open Access | Times Cited: 100
Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions
Rucha Pandit, Gerhard Leinenga, Jürgen Götz
Theranostics (2019) Vol. 9, Iss. 13, pp. 3754-3767
Open Access | Times Cited: 99
Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 17, pp. 7640-7656
Open Access | Times Cited: 98
Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2018) Vol. 158, pp. 359-375
Closed Access | Times Cited: 94
Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
Shanya Jiang, Kiran Bhaskar
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 84
Copper-Targeting Approaches in Alzheimer’s Disease: How To Improve the Fallouts Obtained from in Vitro Studies
Charlène Esmieu, Djamila Guettas, Amandine Conte‐Daban, et al.
Inorganic Chemistry (2019) Vol. 58, Iss. 20, pp. 13509-13527
Open Access | Times Cited: 77
Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease
Yuanyuan Shen, Lingchen Hua, Chih‐Kuang Yeh, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11794-11819
Open Access | Times Cited: 72
Adolescent Binge Alcohol Enhances Early Alzheimer’s Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation
Alexandra Barnett, Emeraghi David, Aaron Rohlman, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 47
Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation
Sivaprakasam R. Saroja, Kirill Gorbachev, Julia TCW, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 34
Open Access | Times Cited: 45
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 42
Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials
Tanzeel Khan, Rashid Waseem, Mohammad Shahid, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102113-102113
Closed Access | Times Cited: 28

Scroll to top